Literature DB >> 19726791

Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions.

Mei Neni Sitaresmi1, Saskia Mostert, Ignatius Purwanto, Chad M Gundy, Anjo J P Veerman.   

Abstract

Noncompliance with prescribed medication has been associated with increased chance of relapse and poor outcome. Side effects may be an important cause of noncompliance. Fifty-one parents of children with acute lymphoblastic leukemia in a tertiary care hospital in Indonesia were interviewed about their perception of side effects and their impact on treatment noncompliance and daily activities. A symptom checklist assessing 13 common symptoms was used to examine side effects. During chemotherapy, childhood acute lymphoblastic leukemia patients suffered from psychological as well as physical side effects. The most frequent side effect reported by parents was behavior alteration (92%). Second and third in frequency were increased appetite and infections, reported by 88% and 83% of parents, respectively. The most severe side effects were leg weakness, increased appetite, and behavior alteration. The overall frequency of side effects was weakly correlated to noncompliance. Reducing the impact of side effects may increase compliance with the treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726791     DOI: 10.1177/1043454209340315

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  4 in total

1.  Initial development of the Symptom Screening in Pediatrics Tool (SSPedi).

Authors:  Deborah Tomlinson; L Lee Dupuis; Paul Gibson; Donna L Johnston; Carol Portwine; Christina Baggott; Sue Zupanec; Julie Watson; Brenda Spiegler; Susan Kuczynski; Gail Macartney; Lillian Sung
Journal:  Support Care Cancer       Date:  2013-08-31       Impact factor: 3.603

2.  Synthesis and Evaluation of Haloacetyl, α-Bromoacryloyl and Nitrooxyacetyl Benzo[b]furan and Benzo[b]thiophene Derivatives as Potent Antiproliferative Agents Against Leukemia L1210 and K562 Cells.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Dora Carrion; Carlota Lopez Cara; Alberto Casolari; Ernest Hamel; Enrica Fabbri; Roberto Gambari
Journal:  Lett Drug Des Discov       Date:  2010-08-01       Impact factor: 1.150

3.  Novel quinazolinone MJ-29 triggers endoplasmic reticulum stress and intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits leukemic mice.

Authors:  Chi-Cheng Lu; Jai-Sing Yang; Jo-Hua Chiang; Mann-Jen Hour; Kuei-Li Lin; Jen-Jyh Lin; Wen-Wen Huang; Minoru Tsuzuki; Tsung-Han Lee; Jing-Gung Chung
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

Review 4.  A systematic review of symptom assessment scales in children with cancer.

Authors:  L Lee Dupuis; Marie-Chantal Ethier; Deborah Tomlinson; Tanya Hesser; Lillian Sung
Journal:  BMC Cancer       Date:  2012-09-26       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.